Preclinical antitumor activity of ST7612AA1: a new oral thiol-based histone deacetylase (HDAC) inhibitor

ST7612AA1 (property of Sigma-Tau), a thioacetate-ω (γ-lactam amide) derivative, is a potent, second generation, oral pan-histone deacetylase inhibitor (HDACi). Aim of the study was to assess the efficacy of ST7612AA1 in solid and haematological tumors, and to characterize its mec...

Descripción completa

Detalles Bibliográficos
Autores principales: Vesci, Loredana, Bernasconi, Elena, Milazzo, Ferdinando Maria, De Santis, Rita, Gaudio, Eugenio, Kwee, Ivo, Rinaldi, Andrea, Pace, Silvia, Carollo, Valeria, Giannini, Giuseppe, Bertoni, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467398/
https://www.ncbi.nlm.nih.gov/pubmed/25671299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467398/
https://www.ncbi.nlm.nih.gov/pubmed/25671299

Ejemplares similares